CPT 81456: RNA Alteration Panel for Solid Organ and Hematolymphoid Cancers
Commercial payers pay $2716 on average nationally for this procedure.
CPT code 81456 describes a genomic sequence analysis panel performed by a laboratory analyst to evaluate a patient specimen (for example, tumor tissue or bone marrow) for RNA alterations across 51 or more genes associated with solid organ cancers or hematolymphoid disorders; the service is a molecular diagnostic genomic test typically performed in a clinical laboratory/pathology setting and reported when comprehensive RNA sequencing for cancer-related gene alterations is completed on the specimen.
For related coverage guidance, see recent payer policy updates: RTM Testing of Homocysteine Metabolism-Related Conditions, Multimarker Serum Testing Related to Ovarian Cancer, Genomic Profiling for Selecting Targeted Cancer Therapies.
Customize your policy alerts
Sign up for cpt 81456 policy alerts
Get alerted when payer policies referencing 81456 are released or updated.
Monitor payer policy activity
National Reimbursement Benchmarks
National commercial reimbursement for CPT 81456 centers near the BUCA average commercial rate of $2,715.70, with notable divergence across major carriers. Blue Cross Blue Shield shows the highest dispersion between its 25th and 75th percentiles (range $1,527.8: $3,620.20 minus $2,092.40 = $1,527.80), indicating broader variability in negotiated rates. Cigna and Aetna also display substantial spreads (Cigna P75–P25 = $2,001.80; Aetna P75–P25 = $914.40), while UnitedHealth Group presents a more compressed interquartile spread of $1,693.40.
Examining central tendency, Cigna and Blue Cross Blue Shield have higher median and mean points relative to UnitedHealth Group, which records a lower median of $1,751.80 and a mean of $2,324.10. BUCA’s mean of $2,715.70 aligns with the upper-middle marketplace position. Overall, dispersion patterns suggest Blue Cross Blue Shield and Cigna offer the widest rate variability, while UnitedHealth Group is comparatively tighter.